BrainChip Reports $13.5M Cash, $1.4M Customer Inflows, and 55 Patents
BrainChip Holdings reported a solid June quarter with $13.5 million in cash, increased customer inflows, and a strategic decision to remain listed on the ASX. The company advanced multiple commercial collaborations and expanded its intellectual property portfolio, signaling confidence in its edge AI technology roadmap.
- Cash balance of US$13.5M supports growth and R&D
- Board opts to remain listed on ASX after redomicile review
- Customer cash inflows rose to US$1.4M, up from US$0.14M
- Expanded global IP portfolio to 55 patents
- Multiple new commercial partnerships and software launches
Financial Stability and Strategic Listing Decision
BrainChip Holdings Ltd closed the June 2025 quarter with a cash balance of US$13.5 million, providing a solid runway for continued investment in research and development. This liquidity position comes despite net operating cash outflows of US$2.8 million, an improvement from the previous quarter's US$4.1 million outflow. Notably, customer cash inflows surged to US$1.4 million, a tenfold increase from the prior quarter, reflecting growing commercial traction.
After an extensive evaluation involving legal and investment banking advisors, the Board concluded that shareholder value would be best served by maintaining its listing on the Australian Securities Exchange (ASX). This decision underscores BrainChip’s commitment to its Australian roots and the ASX’s suitability for supporting its growth ambitions.
Commercial Momentum and Partnerships
BrainChip’s neuromorphic AI technology, embodied in its Akida processor, continues to attract high-profile collaborations. During the quarter, the company partnered with Arquimea to enhance water safety using AI-powered drone detection, and with Andes Technology to integrate Akida with RISC-V embedded cores for efficient edge computing. Additionally, Chelpis Quantum Corp selected Akida chips for industrial robotic security applications, marking a significant step into autonomous robotics.
Further collaborations include strategic work with HaiLa Technologies to combine ultra-low power wireless connectivity with BrainChip’s AI for IoT and medical sensor applications. The company also launched MetaTF 2.13 software and a new Developer Hub, facilitating easier development of intelligent, low-power edge AI applications such as eye-tracking and gesture recognition.
Intellectual Property and Market Positioning
BrainChip expanded its intellectual property portfolio to 55 issued and pending patents across key global markets including the US, Europe, and APAC. This growing IP base strengthens the company’s competitive moat in the rapidly evolving edge AI sector. The company’s marketing efforts remained robust, with active participation in major industry events across the US, Taiwan, and Europe, highlighting Akida’s capabilities and integration potential.
Financially, the company completed a capital call with LDA Capital post-quarter, raising AUD 8.2 million, further bolstering its balance sheet. Operationally, payments to suppliers and employees decreased to US$4.4 million from US$4.9 million, reflecting disciplined cost management.
Looking Ahead
CEO Sean Hehir emphasized BrainChip’s focus on scaling its product portfolio and deepening commercial partnerships to drive revenue growth. The company’s recent demonstrations and collaborations position it well to capitalize on the expanding market for energy-efficient, real-time AI processing at the edge. With nearly five quarters of funding available, BrainChip appears well-equipped to navigate the path toward commercial success.
Bottom Line?
BrainChip’s strong cash position and strategic partnerships set the stage for accelerated growth, but execution in commercialisation will be key to sustaining momentum.
Questions in the middle?
- How will BrainChip convert its growing partnerships into significant revenue streams?
- What are the implications of remaining on the ASX versus a US listing for future capital raises?
- How will the expanding patent portfolio translate into competitive advantage or licensing opportunities?
